Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 125058
Company: BIOMARIN
Company: BIOMARIN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ALDURAZYME | LARONIDASE | 2.9MG/ML | VIAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/30/2003 | ORIG-1 | Approval | N/A; Orphan |
Label (PDF)
Letter Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/larobio043003LB.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/larobio043003L.htm https://web.archive.org/web/20170118085125/https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080438.htm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/14/2023 | SUPPL-246 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125058s246lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125058Orig1s246ltr.pdf | |
12/04/2019 | SUPPL-244 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125058Orig1s244ltr.pdf | |
04/03/2013 | SUPPL-220 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125058Orig1s220ltr.pdf | |
07/13/2011 | SUPPL-209 | Supplement |
Label is not available on this site. |
||
05/14/2010 | SUPPL-186 | Supplement |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125058s0186lbl.pdf | |
05/20/2009 | SUPPL-161 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/125058s0160,125058s0161ltr.pdf | |
05/20/2009 | SUPPL-160 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/125058s0160,125058s0161ltr.pdf | |
08/25/2009 | SUPPL-158 | Supplement |
Label is not available on this site. |
||
04/14/2008 | SUPPL-154 | Supplement |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/125058s154ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/14/2023 | SUPPL-246 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125058s246lbl.pdf | |
12/04/2019 | SUPPL-244 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf | |
04/03/2013 | SUPPL-220 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf | |
05/14/2010 | SUPPL-186 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125058s0186lbl.pdf | |
05/20/2009 | SUPPL-161 | Efficacy | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf | |
05/20/2009 | SUPPL-160 | Efficacy | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125058s160, 125058s161lbl.pdf | |
04/30/2003 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/larobio043003LB.pdf |